Farms.com Home   News

New Opportunities Developing for U.S. Beef in China’s Foodservice Sector

China’s economy is off to a good start in 2023 as consumer spending rallies from extended pandemic restrictions. Foodservice is rebounding and importers are working aggressively with its restaurant customers to meet changing demand from consumers.  The pursuit of fresh ideas is creating new opportunities for high-quality, grain-fed U.S. beef in a sector that is accustomed to lean, grass-fed beef from South America.

USMEF partnered with a key importer to conduct training on specific U.S. beef cuts for one of its customers, a hot pot chain with more than 150 outlets in top tier cities. The CEO of the restaurant chain joined members of its research and development and quality control teams and Shanghai Podun staff for the seminar, led by USMEF China Director Polly Zhao. She provided an overview of U.S. beef production with an emphasis on how structured grain-feeding programs in the United States contribute to the marbling that fosters cut versatility and creates superior flavor in U.S. beef.

“Shanghai Podun imports large volumes of U.S. beef every month and sees expanding opportunities to grow sales with many of its foodservice customers, including this chain,” says Zhao.

A guest chef delivered a cutting presentation to demonstrate the versatility and profitability of using several U.S. beef cuts, including chuck roll, boneless chuck short ribs, short plate, ribeye and top blade. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.